4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Screening for carriage of carbapenem-resistant Enterobacteriaceae in settings of high endemicity: a position paper from an Italian working group on CRE infections

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          A variety of national and international guidelines exist around the management of carbapenem resistant Enterobacteriaceae (CREs), but some of these are several years old and do not reflect current epidemiology and they also do not necessarily give pragmatic advice around active surveillance of CREs in countries with a high burden of cases and limited resources. This paper aims to provide a best practice position paper to guide active surveillance in a variety of scenarios in these settings, and discusses which patients should be screened, what methods could be used for screening, and how results might influence infection prevention interventions.

          Methods

          This paper was developed as a result of a series of meetings of expert opinion leaders representing the major infectious disease and infection prevention societies in Italy and having the endorsement of AMCLI (Italian Association of Clinical Microbiology) and SITA (Italian Society for Anti-infective Therapy). There was no attempt to undertake a full systematic review of the evidence, as it was felt that this was inadequate to inform a pragmatic view on the best way forward based on current epidemiology and infection rates.

          Key recommendations

          Key recommendations focus on the urgent need to promote measures to prevent transmission and infection, focusing on high risk patients and clinical areas, as well as outbreak situations. Active surveillance leading to appropriate infection prevention precautions plays a major role in this.

          Conclusions

          There are limited national or international guidelines giving pragmatic advice on the most appropriate measures for active surveillance and management of colonized patients in a high-burden setting such as Italy. While individual hospitals and regions will need to formulate their own policies based on local epidemiology, this position paper attempts to highlight current best practice in this area and provide pragmatic advice for clinicians, infection prevention staff, and healthcare managers.

          Related collections

          Most cited references42

          • Record: found
          • Abstract: found
          • Article: not found

          Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study.

          Gaps in the diagnostic capacity and heterogeneity of national surveillance and reporting standards in Europe make it difficult to contain carbapenemase-producing Enterobacteriaceae. We report the development of a consistent sampling framework and the results of the first structured survey on the occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in European hospitals.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Risk of infection following colonization with carbapenem-resistant Enterobactericeae: A systematic review.

            Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as important health care-associated pathogens. Colonization precedes infection but the risk of developing infection amongst those colonized with CRE is not clear.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Identification and screening of carbapenemase-producing Enterobacteriaceae.

              Carbapenem-hydrolysing β-lactamases are the most powerful β-lactamases, being able to hydrolyse almost all β-lactams. They are mostly of the KPC, VIM, IMP, NDM and OXA-48 types. Their current extensive spread worldwide in Enterobacteriaceae is an important source of concern, as these carbapenemase producers are multidrug-resistant. Detection of infected patients and of carriers are the two main approaches for prevention of their spread. Phenotypic and molecular-based techniques are able to identify these carbapenemase producers, although with variable efficiencies. The detection of carriers still relies mostly on the use of screening culture media. © 2012 The Authors. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.
                Bookmark

                Author and article information

                Contributors
                simone.ambretti@aosp.bo.it
                matteo.bassetti@asuiud.sanita.fvg.it
                pierangelo.clerici@asst-ovestmi.it
                nicola.petrosillo@inmi.it
                fabio.tumietto@unibo.it
                pierluigi.viale@unibo.it
                gianmaria.rossolini@unifi.it
                Journal
                Antimicrob Resist Infect Control
                Antimicrob Resist Infect Control
                Antimicrobial Resistance and Infection Control
                BioMed Central (London )
                2047-2994
                13 August 2019
                13 August 2019
                2019
                : 8
                : 136
                Affiliations
                [1 ]GRID grid.412311.4, Unit of Clinical Microbiology, , St Orsola-Malpighi University Hospital, ; Bologna, Via Massarenti 9, 40138 Bologna, Italy
                [2 ]GRID grid.411492.b, Infectious Diseases Clinic, , Department of Medicine University of Udine and Azienda Sanitaria Universitaria Integrata di Udine, ; Udine, Italy
                [3 ]Microbiological Unit, Department of Laboratory Medicine and Diagnostics Biotecnology, Azienda Socio Sanitaria Territoriale Ovest Milanese, Via Giovanni Paolo II, 2025 Legnano, Mi Italy
                [4 ]ISNI 0000 0004 1760 4142, GRID grid.419423.9, National Institute for Infectious Diseases “L. Spallanzani”, ; IRCCS-, Rome, Italy
                [5 ]ISNI 0000 0004 1757 1758, GRID grid.6292.f, Infectious Diseases Unit, Department of Medical and Surgical Sciences, S.Orsola-Malpighi Hospital, , University of Bologna, ; Via Massarenti 9, 40138 Bologna, Italy
                [6 ]ISNI 0000 0004 1757 2304, GRID grid.8404.8, Department of Experimental and Clinical Medicine, , University of Florence, and Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, ; Florence, Italy
                Author information
                http://orcid.org/0000-0002-8358-339X
                Article
                591
                10.1186/s13756-019-0591-6
                6693230
                31423299
                78efb146-b38c-47b2-abad-e185107fdf92
                © The Author(s). 2019

                Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 6 June 2019
                : 31 July 2019
                Categories
                Review
                Custom metadata
                © The Author(s) 2019

                Infectious disease & Microbiology
                carbapenem-resistant,enterobacteriaceae,active surveillance,infection control

                Comments

                Comment on this article